How Effective Is Steroid Combination Therapy For High-risk Cases Of Kawasaki Disease?

被引：0
|
作者：
Yoshikane, Yukako
Hashimoto, Junichi
Hirose, Shinichi
机构：
来源：
CIRCULATION | 2015年 / 131卷
关键词：
Kawasaki disease;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
149
引用
收藏
页数：2
相关论文
共 50 条
  • [21] PENTOXIFYLLINE AND INTRAVENOUS GAMMA-GLOBULIN COMBINATION THERAPY FOR ACUTE KAWASAKI-DISEASE
    FURUKAWA, S
    MATSUBARA, T
    UMEZAWA, Y
    MOTOHASHI, T
    INO, T
    YABUTA, K
    EUROPEAN JOURNAL OF PEDIATRICS, 1994, 153 (09) : 663 - 667
  • [22] High Regression Rate of Coronary Aneurysms Developed in Patients with Immune Globulin-Resistant Kawasaki Disease Treated with Steroid Pulse Therapy
    Adachi, Shinya
    Sakaguchi, Heima
    Kuwahara, Takashi
    Uchida, Yasushi
    Fukao, Toshiyuki
    Kondo, Naomi
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 220 (04) : 285 - 290
  • [23] Long term Prognosis After Methylprednisolon pulse Combination Therapy For Refractory Kawasaki Disease
    Ebato, Takasuke
    Ogihara, Yoshihito
    Takanashi, Manabu
    Honda, Takashi
    Kimura, Sumito
    Ogata, Shohei
    Ishii, Masahiro
    CIRCULATION, 2015, 131
  • [24] New predictors to identify severe cases during intravenous immunoglobulin therapy in Kawasaki disease
    Iwasa, Mitsuji
    Inukai, Sachiko
    PEDIATRICS INTERNATIONAL, 2022, 64 (01)
  • [25] High-dose aspirin for Kawasaki disease: outdated myth or effective aid?
    Amarilyo, G.
    Koren, Y.
    Simon, D. Brik
    Bar-Meir, M.
    Bahat, H.
    Helou, M. H.
    Mendelson, A.
    Hezkelo, N.
    Chodick, G.
    Berkun, Y.
    Eisenstein, E.
    Aviel, Y. Butbul
    Barkai, G.
    Bolkier, Y.
    Padeh, S.
    Brik, R.
    Hashkes, P. J.
    Harel, L.
    Uziel, Y.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (01) : S209 - S212
  • [26] Should Infliximab be Used as an Adjuvant to IVIG in the Treatment of Children With Kawasaki Disease Who Are at High Risk for Resistance to Conventional Therapy?
    Shelby Davies
    Gabrielle Gold-von Simson
    Pediatric Cardiology, 2013, 34 : 1756 - 1756
  • [27] Should Infliximab be Used as an Adjuvant to IVIG in the Treatment of Children With Kawasaki Disease Who Are at High Risk for Resistance to Conventional Therapy?
    Davies, Shelby
    Gold-von Simson, Gabrielle
    PEDIATRIC CARDIOLOGY, 2013, 34 (07) : 1756 - 1756
  • [28] The strategy of immune globulin resistant Kawasaki disease: A comparative study of additional immune globulin and steroid pulse therapy
    Ogata, Shohei
    Bando, Yuki
    Kimura, Sumito
    Ando, Hisashi
    Nakahata, Yayoi
    Ogihara, Yoshihito
    Kaneko, Tadahiro
    Minoura, Katsunori
    Kaida, Miho
    Yokota, Yukifumi
    Furukawa, Shinsuke
    Ishii, Masahiro
    JOURNAL OF CARDIOLOGY, 2009, 53 (01) : 15 - 19
  • [29] Functional benefits of corticosteroid and IVIG combination therapy in a coronary artery endothelial cell model of Kawasaki disease
    Takashi Inoue
    Shokei Murakami
    Kenji Matsumoto
    Akio Matsuda
    Pediatric Rheumatology, 18
  • [30] Functional benefits of corticosteroid and IVIG combination therapy in a coronary artery endothelial cell model of Kawasaki disease
    Inoue, Takashi
    Murakami, Shokei
    Matsumoto, Kenji
    Matsuda, Akio
    PEDIATRIC RHEUMATOLOGY, 2020, 18 (01)
12345